Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia.

Inagawa Y, Komeno Y, Saito S, Maenohara Y, Yamagishi T, Kawashima H, Saito T, Abe K, Iihara K, Hatada Y, Ryu T.

Case Rep Hematol. 2019 Nov 27;2019:1616237. doi: 10.1155/2019/1616237. eCollection 2019.

2.

Hemophagocytic Syndrome-Associated Variant of Methotrexate-Associated Intravascular Large B-Cell Lymphoma in a Rheumatoid Arthritis Patient.

Komeno Y, Akiyama M, Okochi Y, Tokuda H, Abe K, Iihara K, Ryu T.

Case Rep Hematol. 2019 Sep 11;2019:8947616. doi: 10.1155/2019/8947616. eCollection 2019.

3.

Secondary Syphilis with Tonsillar and Cervical Lymphadenopathy and a Pulmonary Lesion Mimicking Malignant Lymphoma.

Komeno Y, Ota Y, Koibuchi T, Imai Y, Iihara K, Ryu T.

Am J Case Rep. 2018 Mar 4;19:238-243.

4.

Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.

Komeno Y, Uchida N, Satoh Y, Uryu H, Iwata Y, Masuda A, Iihara K, Yatomi Y, Taniguchi S, Ryu T.

Oncol Lett. 2017 Jun;13(6):4285-4289. doi: 10.3892/ol.2017.5989. Epub 2017 Apr 5.

5.

Splenic Marginal Zone Lymphoma with Acquired von Willebrand Syndrome Diagnosed via Splenic Bleeding.

Komeno Y, Shibuya N, Uryu H, Yamada H, Toda T, Shibasaki M, Kunishima S, Iihara K, Ryu T.

Intern Med. 2017;56(5):557-562. doi: 10.2169/internalmedicine.56.7258. Epub 2017 Mar 1.

6.

Intestinal Intravascular Large B-cell Lymphoma Mimicking Ulcerative Colitis with Secondary Membranoproliferative Glomerulonephritis.

Kaneyuki D, Komeno Y, Yoshimoto H, Yoshimura N, Iihara K, Ryu T.

Intern Med. 2016;55(17):2475-81. doi: 10.2169/internalmedicine.55.6737. Epub 2016 Sep 1.

7.

Esophageal Candidiasis as the Initial Manifestation of Acute Myeloid Leukemia.

Komeno Y, Uryu H, Iwata Y, Hatada Y, Sakamoto J, Iihara K, Ryu T.

Intern Med. 2015;54(23):3087-92. doi: 10.2169/internalmedicine.54.4613. Epub 2015 Dec 1.

8.

Novel working hypothesis for pathogenesis of hematological malignancies: combination of mutations-induced cellular phenotypes determines the disease (cMIP-DD).

Kitamura T, Watanabe-Okochi N, Enomoto Y, Nakahara F, Oki T, Komeno Y, Kato N, Doki N, Uchida T, Kagiyama Y, Togami K, Kawabata KC, Nishimura K, Hayashi Y, Nagase R, Saika M, Fukushima T, Asada S, Fujino T, Izawa Y, Horikawa S, Fukuyama T, Tanaka Y, Ono R, Goyama S, Nosaka T, Kitaura J, Inoue D.

J Biochem. 2016 Jan;159(1):17-25. doi: 10.1093/jb/mvv114. Epub 2015 Nov 20. Review.

9.

SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.

Komeno Y, Huang YJ, Qiu J, Lin L, Xu Y, Zhou Y, Chen L, Monterroza DD, Li H, DeKelver RC, Yan M, Fu XD, Zhang DE.

Mol Cell Biol. 2015 Sep 1;35(17):3071-82. doi: 10.1128/MCB.00202-15. Epub 2015 Jun 29.

10.

AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation.

Gao XN, Yan F, Lin J, Gao L, Lu XL, Wei SC, Shen N, Pang JX, Ning QY, Komeno Y, Deng AL, Xu YH, Shi JL, Li YH, Zhang DE, Nervi C, Liu SJ, Yu L.

Leukemia. 2015 Aug;29(8):1730-40. doi: 10.1038/leu.2015.56. Epub 2015 Mar 2.

PMID:
25727291
11.

The molecular basis of myeloid malignancies.

Kitamura T, Inoue D, Okochi-Watanabe N, Kato N, Komeno Y, Lu Y, Enomoto Y, Doki N, Uchida T, Kagiyama Y, Togami K, Kawabata KC, Nagase R, Horikawa S, Hayashi Y, Saika M, Fukuyama T, Izawa K, Oki T, Nakahara F, Kitaura J.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(10):389-404. Review.

12.

Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.

Nakahara F, Kitaura J, Uchida T, Nishida C, Togami K, Inoue D, Matsukawa T, Kagiyama Y, Enomoto Y, Kawabata KC, Chen-Yi L, Komeno Y, Izawa K, Oki T, Nagae G, Harada Y, Harada H, Otsu M, Aburatani H, Heissig B, Hattori K, Kitamura T.

Blood. 2014 Jun 19;123(25):3932-42. doi: 10.1182/blood-2013-01-476747. Epub 2014 May 13.

PMID:
24825862
13.

Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice.

Komeno Y, Yan M, Matsuura S, Lam K, Lo MC, Huang YJ, Tenen DG, Downing JR, Zhang DE.

Blood. 2014 Jun 12;123(24):3760-9. doi: 10.1182/blood-2013-08-521252. Epub 2014 Apr 25.

14.

Cooperation between RUNX1-ETO9a and novel transcriptional partner KLF6 in upregulation of Alox5 in acute myeloid leukemia.

DeKelver RC, Lewin B, Lam K, Komeno Y, Yan M, Rundle C, Lo MC, Zhang DE.

PLoS Genet. 2013;9(10):e1003765. doi: 10.1371/journal.pgen.1003765. Epub 2013 Oct 10.

15.

Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.

Kagiyama Y, Kitaura J, Togami K, Uchida T, Inoue D, Matsukawa T, Izawa K, Kawabata KC, Komeno Y, Oki T, Nakahara F, Sato K, Aburatani H, Kitamura T.

Int J Hematol. 2012 Nov;96(5):638-48. doi: 10.1007/s12185-012-1207-6. Epub 2012 Oct 25.

PMID:
23097187
16.

Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.

Matsuura S, Komeno Y, Stevenson KE, Biggs JR, Lam K, Tang T, Lo MC, Cong X, Yan M, Neuberg DS, Zhang DE.

Blood. 2012 Nov 8;120(19):4028-37. doi: 10.1182/blood-2012-01-404533. Epub 2012 Aug 23.

17.

Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.

Lo MC, Peterson LF, Yan M, Cong X, Jin F, Shia WJ, Matsuura S, Ahn EY, Komeno Y, Ly M, Ommen HB, Chen IM, Hokland P, Willman CL, Ren B, Zhang DE.

Blood. 2012 Aug 16;120(7):1473-84. doi: 10.1182/blood-2011-12-395335. Epub 2012 Jun 26.

18.

PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.

Shia WJ, Okumura AJ, Yan M, Sarkeshik A, Lo MC, Matsuura S, Komeno Y, Zhao X, Nimer SD, Yates JR 3rd, Zhang DE.

Blood. 2012 May 24;119(21):4953-62. doi: 10.1182/blood-2011-04-347476. Epub 2012 Apr 12.

19.

Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.

Oki T, Kitaura J, Watanabe-Okochi N, Nishimura K, Maehara A, Uchida T, Komeno Y, Nakahara F, Harada Y, Sonoki T, Harada H, Kitamura T.

Leukemia. 2012 May;26(5):1038-45. doi: 10.1038/leu.2011.328. Epub 2011 Nov 25.

PMID:
22116551
20.

Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis.

Nakamura M, Kitaura J, Enomoto Y, Lu Y, Nishimura K, Isobe M, Ozaki K, Komeno Y, Nakahara F, Oki T, Kume H, Homma Y, Kitamura T.

Cancer Sci. 2012 Jan;103(1):26-33. doi: 10.1111/j.1349-7006.2011.02108.x. Epub 2011 Nov 1.

21.

Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models.

Kato N, Kitaura J, Doki N, Komeno Y, Watanabe-Okochi N, Togami K, Nakahara F, Oki T, Enomoto Y, Fukuchi Y, Nakajima H, Harada Y, Harada H, Kitamura T.

Blood. 2011 Jan 6;117(1):221-33. doi: 10.1182/blood-2010-02-270181. Epub 2010 Sep 30.

PMID:
20884804
22.

TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, Nakamura M, Yamazaki S, Enomoto Y, Oki T, Akiba H, Abe T, Komori T, Morikawa Y, Kiyonari H, Takai T, Okumura K, Kitamura T.

J Exp Med. 2010 Jul 5;207(7):1501-11. doi: 10.1084/jem.20090581. Epub 2010 Jun 21.

23.

AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.

Komeno Y, Kitaura J, Watanabe-Okochi N, Kato N, Oki T, Nakahara F, Harada Y, Harada H, Shinkura R, Nagaoka H, Hayashi Y, Honjo T, Kitamura T.

Leukemia. 2010 May;24(5):1018-24. doi: 10.1038/leu.2010.40. Epub 2010 Apr 1.

PMID:
20357822
24.

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, Kumano K, Harada Y, Harada H, Kitaura J, Ogawa S, Kurokawa M, Kitamura T, Chiba S.

Blood. 2010 Apr 8;115(14):2872-81. doi: 10.1182/blood-2009-05-222836. Epub 2009 Oct 27.

PMID:
19861684
25.

Possible involvement of RasGRP4 in leukemogenesis.

Watanabe-Okochi N, Oki T, Komeno Y, Kato N, Yuji K, Ono R, Harada Y, Harada H, Hayashi Y, Nakajima H, Nosaka T, Kitaura J, Kitamura T.

Int J Hematol. 2009 May;89(4):470-481. doi: 10.1007/s12185-009-0299-0. Epub 2009 Apr 7.

PMID:
19350351
26.

Molecular bases of myelodysplastic syndromes: lessons from animal models.

Komeno Y, Kitaura J, Kitamura T.

J Cell Physiol. 2009 Jun;219(3):529-34. doi: 10.1002/jcp.21739. Review.

PMID:
19259975
27.

Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.

Miyazaki K, Yamasaki N, Oda H, Kuwata T, Kanno Y, Miyazaki M, Komeno Y, Kitaura J, Honda Z, Warming S, Jenkins NA, Copeland NG, Kitamura T, Nakamura T, Honda H.

Blood. 2009 May 7;113(19):4702-10. doi: 10.1182/blood-2007-05-088724. Epub 2009 Feb 20.

PMID:
19234145
28.

AML1 mutations induced MDS and MDS/AML in a mouse BMT model.

Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y, Nakajima H, Nosaka T, Inaba T, Kitamura T.

Blood. 2008 Apr 15;111(8):4297-308. doi: 10.1182/blood-2007-01-068346. Epub 2008 Jan 11.

PMID:
18192504
29.

Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD.

Lu Y, Kitaura J, Oki T, Komeno Y, Ozaki K, Kiyono M, Kumagai H, Nakajima H, Nosaka T, Aburatani H, Kitamura T.

Leukemia. 2007 Nov;21(11):2246-57. Epub 2007 Aug 9.

PMID:
17690703
30.

Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutations.

Nishiyama U, Yoshino T, Ozai M, Yoshioka R, Fujisawa M, Ogasawara Y, Kitahori M, Yoshioka E, Kubo K, Komeno Y, Kurokawa M, Ogawa S, Chiba S, Osawa T, Kuwaki T, Hirai H, Miwa A.

Leuk Res. 2006 Dec;30(12):1541-6. Epub 2006 Apr 17. Erratum in: Leuk Res. 2007 Oct;31(10):1457.

PMID:
16603240
31.

A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors.

Komeno Y, Kanda Y, Hamaki T, Mitani K, Iijima K, Ueyama J, Yoshihara S, Yuji K, Kim SW, Ando T, Kami M, Yamamoto E, Hiruma K, Mori S, Hirai H, Sakamaki H; Japan Hematology and Oncology Clinical Study Group.

Biol Blood Marrow Transplant. 2006 Apr;12(4):408-13.

32.

Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinase.

Komeno Y, Kurokawa M, Imai Y, Takeshita M, Matsumura T, Kubo K, Yoshino T, Nishiyama U, Kuwaki T, Kubo K, Osawa T, Ogawa S, Chiba S, Miwa A, Hirai H.

Leukemia. 2005 Jun;19(6):930-5.

PMID:
15815726
33.

A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.

Hori A, Kanda Y, Goyama S, Onishi Y, Komeno Y, Mitani K, Kishi Y, Ogawa S, Imataki O, Chiba S, Kojima R, Hamaki T, Sakiyama M, Kami M, Makimoto A, Tanosaki R, Takaue Y, Hirai H; Japan Hematology and Oncology Clinical Study Group.

Transplantation. 2005 Feb 15;79(3):372-4.

PMID:
15699774
34.

Clinical significance of peripheral blood erythroblastosis after hematopoietic stem cell transplantation.

Goyama S, Kanda Y, Nannya Y, Ogawa S, Asano-Moki Y, Ogawa N, Nakagawa M, Sakata-Yanagimoto M, Kawazu M, Komeno Y, Imai Y, Hangaishi A, Kurokawa M, Tsujino S, Aoki K, Chiba S, Motokura T, Hirai H.

Leuk Lymphoma. 2004 Dec;45(12):2439-43.

PMID:
15621756
35.

Ischemic colitis as a manifestation of thrombotic microangiopathy following bone marrow transplantation.

Komeno Y, Ogawa S, Ishida T, Takeuchi K, Tsujino S, Kurokawa M, Aoki K, Kanda Y, Chiba S, Motokura T, Fukayama M, Hirai H.

Intern Med. 2003 Dec;42(12):1228-32.

36.

[A case with myositis as a manifestation of chronic graft-versus-host-disease (GVHD) with severe muscle swelling developed after aggressive muscular exercise].

Kano S, Shimizu J, Mikata T, Shinoe T, Ota H, Komeno Y, Ogawa S, Hirai H, Kanazawa I.

Rinsho Shinkeigaku. 2003 Mar;43(3):93-7. Japanese.

PMID:
12820556
37.

Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.

Komeno Y, Kanda Y, Kandabashi K, Kawazu M, Goyama S, Takeshita M, Nannya Y, Niino M, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Hirai H.

Am J Hematol. 2003 Mar;72(3):220-2.

38.

Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation.

Goyama S, Kanda Y, Nannya Y, Kawazu M, Takeshita M, Niino M, Komeno Y, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Shiratori Y, Hirai H.

Leuk Lymphoma. 2002 Nov;43(11):2159-63. Review.

PMID:
12533042
39.

Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid.

Kawazu M, Kanda Y, Goyama S, Takeshita M, Nannya Y, Niino M, Komeno Y, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Ohishi N, Hirai H.

Am J Hematol. 2003 Jan;72(1):27-30.

40.

[A case of gliomatosis cerebri in an elderly woman].

Komeno Y, Ako J, Shimada Y, Namba Y, Matsuse T, Toba K, Ouchi Y.

Nihon Ronen Igakkai Zasshi. 2001 Jul;38(4):540-3. Japanese.

41.

Tacrolimus in corticosteroid-resistant ulcerative colitis.

Matsuhashi N, Nakajima A, Watanabe K, Komeno Y, Suzuki A, Ohnishi S, Omata M, Kondo K, Usui Y, Iwadare JI, Watanabe T, Nagawa H, Muto T.

J Gastroenterol. 2000;35(8):635-40.

PMID:
10955604

Supplemental Content

Loading ...
Support Center